These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 772906

  • 1. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R, Gagnon MA, Gauthier R, Jéquier JC.
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract] [Full Text] [Related]

  • 2. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A, Pineau R, Jus K, Villeneuve A, Gautier J, Pires P, Drolet A, Cote M, Villeneuve R.
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract] [Full Text] [Related]

  • 3. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H, Vereecken JL, Tanghe A.
    Psychiatr Neurol Neurochir; 1973 Oct; 76(4):251-9. PubMed ID: 4581374
    [No Abstract] [Full Text] [Related]

  • 4. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
    Degkwitz R, Bauer MP, Gruber M, Hampel G, Luxenburger O, Richartz M, Wenzel W.
    Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
    [No Abstract] [Full Text] [Related]

  • 5. An attempt to classify neuroleptic drugs on the basis of short-term clinical comparative studies.
    Rodová A, Náhunek K, Svestka J.
    Act Nerv Super (Praha); 1974 Aug; 16(3):169-70. PubMed ID: 4609274
    [No Abstract] [Full Text] [Related]

  • 6. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM, Varga V.
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract] [Full Text] [Related]

  • 7. The extrapyramidal neuroleptic syndrome: description and measurement.
    Elie R, Gagnon MA, Lamontagne Y, Tetreault L.
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):427-40. PubMed ID: 4198304
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The depot neuroleptic agent fluspirilene (author's transl)].
    Angst J, Frei M, Scharfetter Chr.
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
    [No Abstract] [Full Text] [Related]

  • 12. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C, Dimascio A, Demirgian E.
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT, Stenson RL.
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [Abstract] [Full Text] [Related]

  • 15. The purely neuroleptic effects and its relation to the "neuroleptic threshold".
    Haase HJ.
    Acta Psychiatr Belg; 1978 Nov; 78(1):19-36. PubMed ID: 645405
    [Abstract] [Full Text] [Related]

  • 16. [Trial of interruption of antiparkinson drugs in long term treatments with neuroleptics].
    Caroli F, Littre-Poirier MF, Ginestet D, Deniker P.
    Encephale; 1975 Nov; 1(1):69-74. PubMed ID: 805695
    [Abstract] [Full Text] [Related]

  • 17. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)].
    Bourgeois M, Bouey P.
    Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864
    [No Abstract] [Full Text] [Related]

  • 18. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L, Bordeleau JM, Gauthier R, Vulpe M, Lapointe L.
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract] [Full Text] [Related]

  • 19. [Usefulness for differential diagnosis of the distribution of extrapyramidal symptoms resulting from neuroleptic therapy in psychiatric practice].
    Bódog G.
    Psychiatr Neurol Med Psychol (Leipz); 1976 Jan; 28(1):51-7. PubMed ID: 940883
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.